Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Tramontano AC"'
Publikováno v:
In The Journal of Minimally Invasive Gynecology November-December 2019 26(7) Supplement:S148-S148
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS, McMahon, Pamela M, Kong, Chung Yin, Bouzan, Colleen, Weinstein, Milton C, Cipriano, Lauren E, Tramontano, Angela C, Johnson, Bruce E, Weeks, Jane C, Gazelle, G Scott
Publikováno v:
Journal of Thoracic Oncology; 2011 Nov, Vol. 6 Issue 11, p1841-1848, 8p
Autor:
Iheanacho F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Tramontano AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Manz CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.
Autor:
Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts., Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York., Winer E; Yale Cancer Center, New Haven, Connecticut., Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Cheney MD; Maine Medical Center, Portland, Maine., Hardenbergh P; Vail Health, Vail, Colorado., Ho A; Duke University Medical Center, Durham, North Carolina., Horst KC; Stanford University School of Medicine, Stanford, California., Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington., Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence., Moran MS; Yale Cancer Center, New Haven, Connecticut., Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Soto DE; Massachusetts General Hospital, Boston., Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland., Snyder KM; Northern Light Health, Brewer, Maine., Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland., Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1370-1378.
Autor:
Cotner CE; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Tramontano AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Post A; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Finn B; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Awan S; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Gwynne N; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Mwesigwa S; Mathematica, Cambridge, MA., Lindvall C; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Tulsky JA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Jacobson JO; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jackman DM; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wright AA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Manz CR; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Sep 30, pp. OP2400311. Date of Electronic Publication: 2024 Sep 30.
Autor:
Ozanne EM; Department of Population Health Sciences, School of Medicine, University of Utah, Population Health Sciences, 295 Chipeta Way Rm 1N512, Salt Lake City, UT, 84108, USA. elissa.ozanne@hsc.utah.edu., Maves K; University of Utah, Salt Lake City, UT, USA., Tramontano AC; Division of Population Sciences, Dana-Farber/Partners Cancer Care Institute, Boston, MA, USA., Lynch T; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Thompson A; Baylor College of Medicine, Houston, TX, USA., Partridge A; Dana-Farber Cancer Institute, Boston, MA, USA., Frank E; Alliance Foundation Trials, LLC, Boston, MA, USA., Collyar D; Alliance Foundation Trials, LLC, Boston, MA, USA., Basila D; Alliance Foundation Trials, LLC, Boston, MA, USA., Pinto D; Alliance Foundation Trials, LLC, Boston, MA, USA., Hyslop T; Thomas Jefferson University, Philadelphia, PA, USA., Ryser MD; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Rosenberg S; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Hwang ES; Duke University Medical Center, Durham, NC, USA., Punglia RS; Department of Radiation Oncology, Dana-Farber/Partners Cancer Care, Boston, MA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Sep 17; Vol. 26 (1), pp. 134. Date of Electronic Publication: 2024 Sep 17.
Autor:
Lee DJ; Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., El-Khoury H; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Alberge JB; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Davis MI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Redd R; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Sakrikar D; The Binding Site Inc, Rochester, MN., Barnidge D; The Binding Site Inc, Rochester, MN., Perkins MC; The Binding Site Group Ltd, Birmingham, United Kingdom., Harding S; The Binding Site Group Ltd, Birmingham, United Kingdom., Mucci L; Harvard T.H. Chan School of Public Health, Boston, MA., Rebbeck TR; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard T.H. Chan School of Public Health, Boston, MA., Ghobrial IM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA., Marinac CR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1737-1746.
Autor:
Paudel R; Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Dana-Farber Cancer Institute, Boston, MA., Cronin C; Dana-Farber Cancer Institute, Boston, MA., Wong SL; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Dizon DS; Lifespan Cancer Institute and Brown University, Providence, RI., Jenkins HH; West Virginia University Cancer Center, Morgantown, WV., Bian J; Maine Medical Center, Portland, ME., Osarogiagbon RU; Baptist Memorial Healthcare Corporation, Memphis, TN., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jan; Vol. 20 (1), pp. 77-84. Date of Electronic Publication: 2023 Nov 27.
Autor:
Kuczmarski TM; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Tramontano AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Mozessohn L; Department of Hematology and Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., LaCasce AS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA., Roemer L; Department of Psychology, University of Massachusetts, Boston, MA, USA., Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA., Odejide OO; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Oreofe_Odejide@dfci.harvard.edu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Jul; Vol. 10 (7), pp. e530-e538. Date of Electronic Publication: 2023 Jun 01.